1Larosa JC,Grundy SM,waters DD,et al.Intensive Lipid Lowering with Atorvastatin in Patients with stable coronary disease[J].N Eng J Med,2005,352(14):1425-1435.
2Clarenbach JJ,Reber M,Lutjohann D.et a1.The lipid-lowering effect of ezetimibe in pure vegetarians[J].J Lipid Res,2006,47(12):2820-2840.
4Neal RC,Jones PH.Complementary therapy to target LDL cholesterol:the role of the ezetimibe/simvastatin combination[J].Vasc Health Risk Manag,2006,2(1):31-38.
7De Seigneux S, Martin PY. Management of patients with ne- phrotic syndrome [ J]. Swiss Med Wldy, 2009,139 ( 29-30 ) : 416-422.
8Trevisan R, Dodesini AR, Lepore G. Lipids and renal disease [ J]. J Am Soc Nephrol,2006,17 (4 Suppl 2) : S145-S147.
9D'Amico G. Statins and renal diseases:from primary prevention to renal replacement therapy[J]. J Am Soc Nephrol,2006,17 (4 Suppl 2) :S148-S152.
10Heber D, Yip I, Ashley JM, et al. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement[ J]. Am J Clin Nutr, 1999,69:231-236.
